Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Patients with inflammatory bowel disease involving the colon are at increased risk for developing colorectal cancer. Colonoscopy surveillance is important to identify and treat IBD associated dysplasia. The SCENIC consensus provides evidence-based recommendations for optimal surveillance and management of dysplasia in IBD. Chromoendoscopy, with the surface application of dyes to enhance mucosal visualization, is the superior endoscopic surveillance strategy to detect dysplasia. Most dysplasia is visible, and can be endoscopically resected. Future studies should determine the effect of new surveillance strategies on the incidence of CRC and mortality in patients with IBD.

Original publication

DOI

10.1016/j.bpg.2016.10.014

Type

Journal article

Journal

Best practice & research. Clinical gastroenterology

Publication Date

12/2016

Volume

30

Pages

949 - 958

Addresses

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA, USA.

Keywords

Gastric Mucosa, Humans, Colorectal Neoplasms, Inflammatory Bowel Diseases, Colonoscopy, Population Surveillance, Early Detection of Cancer